Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki disease.

Kuo HC, Liang CD, Yu HR, Wang CL, Lin IC, Liu CA, Chang JC, Lee CP, Chang WC, Yang KD.

J Clin Immunol. 2011 Apr;31(2):240-4. doi: 10.1007/s10875-010-9484-4. Epub 2010 Nov 17.

PMID:
21082224
2.

Association of miR-146a Gene Polymorphism at loci rs2910164 G/C, rs57095329 A/G, and rs6864584 T/C with Susceptibility to Kawasaki Disease in Chinese Children.

Zha L, Li S, Liu X, Li Z, Jiang J, Huang L, Yang Z.

Pediatr Cardiol. 2019 Mar;40(3):504-512. doi: 10.1007/s00246-018-2002-9. Epub 2018 Oct 5.

PMID:
30291383
3.

Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.

Peng Q, Deng Y, Yang X, Leng X, Yang Y, Liu H.

Eur J Pediatr. 2016 May;175(5):705-13. doi: 10.1007/s00431-016-2696-8. Epub 2016 Feb 1.

PMID:
26833052
4.

CD40 Gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population.

Kuo HC, Chao MC, Hsu YW, Lin YC, Huang YH, Yu HR, Hou MF, Liang CD, Yang KD, Chang WC, Wang CL.

ScientificWorldJournal. 2012;2012:520865. doi: 10.1100/2012/520865. Epub 2012 May 2.

5.

Single-nucleotide polymorphism rs7251246 in ITPKC is associated with susceptibility and coronary artery lesions in Kawasaki disease.

Kuo HC, Hsu YW, Lo MH, Huang YH, Chien SC, Chang WC.

PLoS One. 2014 Mar 12;9(3):e91118. doi: 10.1371/journal.pone.0091118. eCollection 2014.

6.

Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease.

Huang YH, Hsu YW, Lu HF, Wong HS, Yu HR, Kuo HC, Huang FC, Chang WC, Kuo HC.

Medicine (Baltimore). 2016 Apr;95(17):e3501. doi: 10.1097/MD.0000000000003501.

7.

Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children.

Huang FY, Chang TY, Chen MR, Lee HC, Chi H, Chiu NC, Hsu CH, Lin SP, Kao HA, Chen WF, Chan HW, Liu HF, Chu CC, Lin M, Lee YJ.

J Clin Immunol. 2008 Jul;28(4):322-8. doi: 10.1007/s10875-008-9185-4. Epub 2008 Feb 23.

PMID:
18297377
8.

Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease.

Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, Mizuno Y, Hara T.

Pediatr Res. 2004 Dec;56(6):953-9. Epub 2004 Oct 6.

PMID:
15470196
9.

Lack of association between E148Q MEFV variant and Kawasaki disease.

Yamaguchi K, Ikeda K, Ihara K, Takada H, Kusuhara K, Hara T.

Hum Immunol. 2009 Jun;70(6):468-71. doi: 10.1016/j.humimm.2008.10.017. Epub 2008 Nov 19.

PMID:
19026701
10.

Genetic variants of CD209 associated with Kawasaki disease susceptibility.

Kuo HC, Huang YH, Chien SC, Yu HR, Hsieh KS, Hsu YW, Chang WC.

PLoS One. 2014 Aug 22;9(8):e105236. doi: 10.1371/journal.pone.0105236. eCollection 2014.

11.

[Single nucleotide polymorphism of FCGR2A gene in Han Chinese children with Kawasaki disease].

Ji YX, Zhang HY, Lin SX.

Zhongguo Dang Dai Er Ke Za Zhi. 2013 Mar;15(3):196-200. Chinese.

12.

CYP2E1 Gene Polymorphisms Related to the Formation of Coronary Artery Lesions in Kawasaki Disease.

Chang LS, Hsu YW, Lu CC, Lo MH, Hsieh KS, Li SC, Chang WC, Kuo HC.

Pediatr Infect Dis J. 2017 Nov;36(11):1039-1043. doi: 10.1097/INF.0000000000001657.

PMID:
28650933
13.

A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease.

Nishimura S, Zaitsu M, Hara M, Yokota G, Watanabe M, Ueda Y, Imayoshi M, Ishii E, Tasaki H, Hamasaki Y.

J Pediatr. 2003 Sep;143(3):357-62.

PMID:
14517520
14.

Major histocompatibility complex class I chain-related gene polymorphisms: associated with susceptibility to Kawasaki disease and coronary artery aneurysms.

Hsieh YY, Chang CC, Hsu CM, Chen SY, Lin WH, Tsai FJ.

Genet Test Mol Biomarkers. 2011 Nov;15(11):755-63. doi: 10.1089/gtmb.2011.0001. Epub 2011 Aug 4.

PMID:
21815799
15.
16.

[The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter].

Yang J, Li CR, Li YB, Li RX, Sun LB, Huang HJ, Wang GB.

Zhonghua Er Ke Za Zhi. 2003 Aug;41(8):598-602. Chinese.

PMID:
14744383
17.

Association of COL11A2 polymorphism with susceptibility to Kawasaki disease and development of coronary artery lesions.

Sheu JJ, Lin YJ, Chang JS, Wan L, Chen SY, Huang YC, Chan C, Chiu IW, Tsai FJ.

Int J Immunogenet. 2010 Dec;37(6):487-92. doi: 10.1111/j.1744-313X.2010.00952.x.

PMID:
20618517
18.

Gene-Gene Associations with the Susceptibility of Kawasaki Disease and Coronary Artery Lesions.

Kuo HC, Chang JC, Guo MM, Hsieh KS, Yeter D, Li SC, Yang KD.

PLoS One. 2015 Nov 30;10(11):e0143056. doi: 10.1371/journal.pone.0143056. eCollection 2015.

19.

Myeloperoxidase genetic polymorphisms and susceptibility to Kawasaki disease in Taiwanese children.

Weng KP, Hsieh KS, Huang SH, Wu HW, Chien JH, Lin CC, Tang CW, Ou SF, Huang SJ, Ger LP.

J Microbiol Immunol Infect. 2016 Oct;49(5):788-796. doi: 10.1016/j.jmii.2015.05.004. Epub 2015 May 14.

20.

TARC/CCL17 gene polymorphisms and expression associated with susceptibility and coronary artery aneurysm formation in Kawasaki disease.

Lee CP, Huang YH, Hsu YW, Yang KD, Chien HC, Yu HR, Yang YL, Wang CL, Chang WC, Kuo HC.

Pediatr Res. 2013 Nov;74(5):545-51. doi: 10.1038/pr.2013.134. Epub 2013 Aug 13.

PMID:
23942559

Supplemental Content

Support Center